Observational study in an outpatient clinic specializing in treating opioid-dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine

被引:0
作者
Metz, Verena E. [1 ,2 ,3 ]
Comer, Sandra D. [1 ,2 ]
Pribasnig, Anna [3 ]
Wuerzl, Johanna [3 ]
Fischer, Gabriele [3 ,4 ]
机构
[1] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
[2] NYSPI, New York, NY 10032 USA
[3] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
[4] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria
关键词
opioid dependence; opioid maintenance therapy; pregnancy; neonatal outcome; breastfeeding; PRENATAL TOBACCO EXPOSURE; BREAST-FEEDING RATES; MAINTENANCE TREATMENT; MANAGEMENT; MOTHERS; BORN; CARE; WITHDRAWAL; SEVERITY; ADDICTS;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The factors determining severity and course of Neonatal Abstinence Syndrome (NAS) in infants born to opioid-dependent pregnant women are still poorly understood. Aim: To compare and evaluate Neonatal Abstinence Syndrome (NAS) in 390 infants born to opioid-dependent women undergoing comprehensive treatment during pregnancy, including methadone (n=184), buprenorphine (n=77) and slow-release oral morphine (SROM, n=129) maintenance therapy. Materials and Methods: An observational design was applied for this complete case analysis, taking into account maternal opioid dose at time of delivery, third trimester concomitant consumption of opioids, benzodiazepines and nicotine, as well as breastfeeding status. Results: The infants exposed to buprenorphine before birth had significantly lower average (p<0.001) and peak NAS scores (p<0.001), needed less morphine for their NAS treatment (p<0.00 I), had shorter mean durations of treatment (p<0.001) and hospital stay (p<0.001) compared with the infants exposed to methadone or SROM. No associations were found between NAS parameters and maternal opioid dose in the buprenorphine group, where concomitant consumption of benzodiazepines and opioids did not influence NAS significantly. Breastfeeding status did not influence NAS in buprenorphine-exposed neonates, in contrast to children in the methadone- or SROM-group. Conclusions: Breastfeeding proved to be especially beneficial to methadone- and SROM-exposed infants whose NAS showed significant, but weak, associations with daily maternal opioid dose. Buprenorphine seems recommendable for women who respond well to it; further research is needed for SROM administration during pregnancy. Cautious interpretation of the results is warranted, because of the individually tailored treatment and subsequent non-random medication group assignment.
引用
收藏
页码:5 / 15
页数:11
相关论文
共 40 条
  • [1] Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers
    Abdel-Latif, Mohamed E.
    Pinner, Jason
    Clews, Sara
    Cooke, Fiona
    Lui, Kei
    Oei, Julee
    [J]. PEDIATRICS, 2006, 117 (06) : E1163 - E1169
  • [2] [Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
  • [3] Influence of Site Differences between Urban and Rural American and Central European Opioid-Dependent Pregnant Women and Neonatal Outcome Characteristics
    Baewert, Andjela
    Jagsch, Reinhold
    Winklbaur, Bernadette
    Kaiser, Gerda
    Thau, Kenneth
    Unger, Annemarie
    Aschauer, Constantin
    Weninger, Manfred
    Metz, Verena
    [J]. EUROPEAN ADDICTION RESEARCH, 2012, 18 (03) : 130 - 139
  • [4] Opioid Maintenance Treatment during Pregnancy: Occurrence and Severity of Neonatal Abstinence Syndrome
    Bakstad, Brittelise
    Sarfi, Monica
    Welle-Strand, Gabrielle K.
    Ravndal, Edle
    [J]. EUROPEAN ADDICTION RESEARCH, 2009, 15 (03) : 128 - 134
  • [5] Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone
    Beck, Thilo
    Haasen, Christian
    Verthein, Uwe
    Walcher, Stephan
    Schuler, Christoph
    Backmund, Markus
    Ruckes, Christian
    Reimer, Jens
    [J]. ADDICTION, 2014, 109 (04) : 617 - 626
  • [6] Berlin CM, 1998, PEDIATRICS, V101, P1079
  • [7] Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure
    Choo, RE
    Huestis, MA
    Schroeder, JR
    Shin, AS
    Jones, HE
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2004, 75 (03) : 253 - 260
  • [8] Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis
    Cleary, Brian J.
    Donnelly, Jean
    Strawbridge, Judith
    Gallagher, Paul J.
    Fahey, Tom
    Clarke, Mike
    Murphy, Deirdre J.
    [J]. ADDICTION, 2010, 105 (12) : 2071 - 2084
  • [9] Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources
    Dryden, C.
    Young, D.
    Hepburn, M.
    Mactiera, H.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (05) : 665 - 671
  • [10] Management of neonatal abstinence syndrome in neonates born to opioid maintained women
    Ebner, Nina
    Rohrmeister, Klaudia
    Winklbaur, Bernadette
    Baewert, Andjela
    Jagsch, Reinhold
    Peternell, Alexandra
    Thau, Kenneth
    Fischer, Gabriele
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2007, 87 (2-3) : 131 - 138